in

Mayo Clinic expands AI-driven biomarker diagnostics partnership

Mayo Clinic expands AI-driven biomarker diagnostics partnership

Mayo Clinic’s new investment in Numares will accelerate the delivery of tests addressing kidney function and cardiac risk that are expected to gain U.S. Food and Drug Administration 510(k) approval early next year, according to the announcement.

WHY IT MATTERS

Using algorithms to analyze multiple biomarkers to measure disease progression in patients can help physicians improve care for those with chronic diseases, including kidney and…


Posted by Editor

LONDON, ENGLAND - NOVEMBER 03: Cynthia Erivo attends the

Cynthia Erivo Shines in Yellow Floral Erdem Trench Dress for ‘Black Panther: Wakanda Forever’ London Premiere

Care4Calais Charity Workers Look After Refugees On The Coast Of Northern France

‘Do-gooders’ and ‘lefty lawyers’ show the compassion this country has abandoned